HEADER OXIDOREDUCTASE 28-JAN-21 7E0S TITLE CRYSTAL STRUCTURE OF HUMAN INDOLEAMINE 2,3-DIOXYGENAGSE 1 (HIDO1) TITLE 2 COMPLEXED WITH (1R,2S)-2-(((6-BROMO-1H-INDAZOL-4-YL)AMINO)METHYL) TITLE 3 CYCLOHEXAN-1-OL (23) COMPND MOL_ID: 1; COMPND 2 MOLECULE: INDOLEAMINE 2,3-DIOXYGENASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: IDO-1,INDOLEAMINE-PYRROLE 2,3-DIOXYGENASE; COMPND 5 EC: 1.13.11.52; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IDO1, IDO, INDO; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS INDOLEAMINE 2, 3-DIOXYGENASE 1, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR G.-B.LI,X.-L.NING REVDAT 2 29-NOV-23 7E0S 1 REMARK REVDAT 1 21-JUL-21 7E0S 0 JRNL AUTH X.L.NING,Y.Z.LI,C.HUO,J.DENG,C.GAO,K.R.ZHU,M.WANG,Y.X.WU, JRNL AUTH 2 J.L.YU,Y.L.REN,Z.Y.LUO,G.LI,Y.CHEN,S.Y.WANG,C.PENG,L.L.YANG, JRNL AUTH 3 Z.Y.WANG,Y.WU,S.QIAN,G.B.LI JRNL TITL X-RAY STRUCTURE-GUIDED DISCOVERY OF A POTENT, ORALLY JRNL TITL 2 BIOAVAILABLE, DUAL HUMAN INDOLEAMINE/TRYPTOPHAN JRNL TITL 3 2,3-DIOXYGENASE (HIDO/HTDO) INHIBITOR THAT SHOWS ACTIVITY IN JRNL TITL 4 A MOUSE MODEL OF PARKINSON'S DISEASE. JRNL REF J.MED.CHEM. V. 64 8303 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34110158 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00303 REMARK 2 REMARK 2 RESOLUTION. 2.71 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.71 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 53.95 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 29844 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.690 REMARK 3 FREE R VALUE TEST SET COUNT : 1996 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 53.9480 - 6.5330 0.98 2081 148 0.1696 0.2239 REMARK 3 2 6.5330 - 5.1868 1.00 2052 147 0.1812 0.2031 REMARK 3 3 5.1868 - 4.5315 1.00 2017 145 0.1464 0.1972 REMARK 3 4 4.5315 - 4.1173 1.00 2001 143 0.1501 0.1967 REMARK 3 5 4.1173 - 3.8223 1.00 1979 142 0.1692 0.2416 REMARK 3 6 3.8223 - 3.5970 1.00 1984 142 0.1914 0.2730 REMARK 3 7 3.5970 - 3.4169 1.00 1977 142 0.2055 0.2728 REMARK 3 8 3.4169 - 3.2682 1.00 1966 141 0.2334 0.3485 REMARK 3 9 3.2682 - 3.1424 1.00 1984 142 0.2562 0.3084 REMARK 3 10 3.1424 - 3.0340 1.00 1978 142 0.2409 0.3326 REMARK 3 11 3.0340 - 2.9391 1.00 1933 139 0.2335 0.2904 REMARK 3 12 2.9391 - 2.8551 1.00 1963 141 0.2370 0.3294 REMARK 3 13 2.8551 - 2.7799 1.00 1956 140 0.2454 0.3268 REMARK 3 14 2.7799 - 2.7121 1.00 1977 142 0.2862 0.3372 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.390 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.570 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 63.21 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 62.26 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.017 6246 REMARK 3 ANGLE : 1.577 8477 REMARK 3 CHIRALITY : 0.061 914 REMARK 3 PLANARITY : 0.009 1075 REMARK 3 DIHEDRAL : 17.597 3713 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7E0S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-FEB-21. REMARK 100 THE DEPOSITION ID IS D_1300020394. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-OCT-20 REMARK 200 TEMPERATURE (KELVIN) : 195 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 X CDTE 1M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROCESS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29941 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.710 REMARK 200 RESOLUTION RANGE LOW (A) : 71.580 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.30 REMARK 200 R MERGE (I) : 0.11800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.71 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.80 REMARK 200 R MERGE FOR SHELL (I) : 1.13500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5ETW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% TO 23% PEG 8000, 0.2M AMMONIUM REMARK 280 ACETATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 42.84300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.11300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.17250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.11300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.84300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.17250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1210 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16310 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1170 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 363 REMARK 465 GLU A 364 REMARK 465 ASN A 365 REMARK 465 LYS A 366 REMARK 465 THR A 367 REMARK 465 SER A 368 REMARK 465 GLU A 369 REMARK 465 ASP A 370 REMARK 465 PRO A 371 REMARK 465 SER A 372 REMARK 465 LYS A 373 REMARK 465 LEU A 374 REMARK 465 GLU A 375 REMARK 465 ALA A 376 REMARK 465 LYS A 377 REMARK 465 GLY A 378 REMARK 465 THR A 379 REMARK 465 GLY A 380 REMARK 465 GLY A 403 REMARK 465 LYS B 363 REMARK 465 GLU B 364 REMARK 465 ASN B 365 REMARK 465 LYS B 366 REMARK 465 THR B 367 REMARK 465 SER B 368 REMARK 465 GLU B 369 REMARK 465 ASP B 370 REMARK 465 PRO B 371 REMARK 465 SER B 372 REMARK 465 LYS B 373 REMARK 465 LEU B 374 REMARK 465 GLU B 375 REMARK 465 ALA B 376 REMARK 465 LYS B 377 REMARK 465 GLY B 378 REMARK 465 THR B 379 REMARK 465 GLY B 380 REMARK 465 GLY B 403 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 13 CG CD CE NZ REMARK 470 LYS B 13 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLU B 402 O HOH B 601 2.14 REMARK 500 OG SER A 263 O1D HEM A 501 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD1 ASP A 98 NZ LYS B 401 3654 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 308 CB CYS A 308 SG -0.141 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 308 CA - CB - SG ANGL. DEV. = -15.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 27 71.66 19.18 REMARK 500 PRO A 33 152.28 -49.80 REMARK 500 LEU A 62 131.44 -29.16 REMARK 500 VAL A 130 -60.13 -121.99 REMARK 500 ASN A 133 54.31 -107.51 REMARK 500 VAL A 229 -70.03 -126.47 REMARK 500 GLU A 254 -123.36 29.71 REMARK 500 ILE A 354 -62.34 -120.55 REMARK 500 THR A 382 -156.14 -65.43 REMARK 500 ASP A 383 59.89 -158.16 REMARK 500 LEU A 384 162.50 57.73 REMARK 500 MET A 385 -68.47 50.50 REMARK 500 PRO B 33 142.06 -34.31 REMARK 500 ASP B 98 89.34 -61.89 REMARK 500 ASN B 133 51.49 -113.07 REMARK 500 VAL B 229 -60.13 -140.57 REMARK 500 LEU B 243 35.23 -149.77 REMARK 500 SER B 244 -36.78 -29.28 REMARK 500 GLU B 250 126.64 -28.87 REMARK 500 PHE B 252 -31.49 -132.38 REMARK 500 ALA B 283 -164.52 -126.40 REMARK 500 ALA B 288 -62.66 -27.34 REMARK 500 ILE B 354 -55.96 -146.91 REMARK 500 THR B 382 -86.10 -47.66 REMARK 500 MET B 385 -55.86 79.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TRP A 253 GLU A 254 127.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 501 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 346 NE2 REMARK 620 2 HEM A 501 NA 90.0 REMARK 620 3 HEM A 501 NB 94.1 90.9 REMARK 620 4 HEM A 501 NC 97.1 172.3 85.5 REMARK 620 5 HEM A 501 ND 92.3 83.9 171.7 98.9 REMARK 620 6 HU6 A 502 N18 174.8 94.1 89.1 79.0 84.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 501 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 346 NE2 REMARK 620 2 HEM B 501 NA 91.6 REMARK 620 3 HEM B 501 NB 86.3 88.0 REMARK 620 4 HEM B 501 NC 88.9 170.2 82.3 REMARK 620 5 HEM B 501 ND 94.7 92.3 179.0 97.5 REMARK 620 6 HU6 B 502 N18 174.3 93.9 95.4 85.9 83.6 REMARK 620 N 1 2 3 4 5 DBREF 7E0S A 12 403 UNP P14902 I23O1_HUMAN 12 403 DBREF 7E0S B 12 403 UNP P14902 I23O1_HUMAN 12 403 SEQRES 1 A 392 SER LYS GLU TYR HIS ILE ASP GLU GLU VAL GLY PHE ALA SEQRES 2 A 392 LEU PRO ASN PRO GLN GLU ASN LEU PRO ASP PHE TYR ASN SEQRES 3 A 392 ASP TRP MET PHE ILE ALA LYS HIS LEU PRO ASP LEU ILE SEQRES 4 A 392 GLU SER GLY GLN LEU ARG GLU ARG VAL GLU LYS LEU ASN SEQRES 5 A 392 MET LEU SER ILE ASP HIS LEU THR ASP HIS LYS SER GLN SEQRES 6 A 392 ARG LEU ALA ARG LEU VAL LEU GLY CYS ILE THR MET ALA SEQRES 7 A 392 TYR VAL TRP GLY LYS GLY HIS GLY ASP VAL ARG LYS VAL SEQRES 8 A 392 LEU PRO ARG ASN ILE ALA VAL PRO TYR CYS GLN LEU SER SEQRES 9 A 392 LYS LYS LEU GLU LEU PRO PRO ILE LEU VAL TYR ALA ASP SEQRES 10 A 392 CYS VAL LEU ALA ASN TRP LYS LYS LYS ASP PRO ASN LYS SEQRES 11 A 392 PRO LEU THR TYR GLU ASN MET ASP VAL LEU PHE SER PHE SEQRES 12 A 392 ARG ASP GLY ASP CYS SER LYS GLY PHE PHE LEU VAL SER SEQRES 13 A 392 LEU LEU VAL GLU ILE ALA ALA ALA SER ALA ILE LYS VAL SEQRES 14 A 392 ILE PRO THR VAL PHE LYS ALA MET GLN MET GLN GLU ARG SEQRES 15 A 392 ASP THR LEU LEU LYS ALA LEU LEU GLU ILE ALA SER CYS SEQRES 16 A 392 LEU GLU LYS ALA LEU GLN VAL PHE HIS GLN ILE HIS ASP SEQRES 17 A 392 HIS VAL ASN PRO LYS ALA PHE PHE SER VAL LEU ARG ILE SEQRES 18 A 392 TYR LEU SER GLY TRP LYS GLY ASN PRO GLN LEU SER ASP SEQRES 19 A 392 GLY LEU VAL TYR GLU GLY PHE TRP GLU ASP PRO LYS GLU SEQRES 20 A 392 PHE ALA GLY GLY SER ALA GLY GLN SER SER VAL PHE GLN SEQRES 21 A 392 CYS PHE ASP VAL LEU LEU GLY ILE GLN GLN THR ALA GLY SEQRES 22 A 392 GLY GLY HIS ALA ALA GLN PHE LEU GLN ASP MET ARG ARG SEQRES 23 A 392 TYR MET PRO PRO ALA HIS ARG ASN PHE LEU CYS SER LEU SEQRES 24 A 392 GLU SER ASN PRO SER VAL ARG GLU PHE VAL LEU SER LYS SEQRES 25 A 392 GLY ASP ALA GLY LEU ARG GLU ALA TYR ASP ALA CYS VAL SEQRES 26 A 392 LYS ALA LEU VAL SER LEU ARG SER TYR HIS LEU GLN ILE SEQRES 27 A 392 VAL THR LYS TYR ILE LEU ILE PRO ALA SER GLN GLN PRO SEQRES 28 A 392 LYS GLU ASN LYS THR SER GLU ASP PRO SER LYS LEU GLU SEQRES 29 A 392 ALA LYS GLY THR GLY GLY THR ASP LEU MET ASN PHE LEU SEQRES 30 A 392 LYS THR VAL ARG SER THR THR GLU LYS SER LEU LEU LYS SEQRES 31 A 392 GLU GLY SEQRES 1 B 392 SER LYS GLU TYR HIS ILE ASP GLU GLU VAL GLY PHE ALA SEQRES 2 B 392 LEU PRO ASN PRO GLN GLU ASN LEU PRO ASP PHE TYR ASN SEQRES 3 B 392 ASP TRP MET PHE ILE ALA LYS HIS LEU PRO ASP LEU ILE SEQRES 4 B 392 GLU SER GLY GLN LEU ARG GLU ARG VAL GLU LYS LEU ASN SEQRES 5 B 392 MET LEU SER ILE ASP HIS LEU THR ASP HIS LYS SER GLN SEQRES 6 B 392 ARG LEU ALA ARG LEU VAL LEU GLY CYS ILE THR MET ALA SEQRES 7 B 392 TYR VAL TRP GLY LYS GLY HIS GLY ASP VAL ARG LYS VAL SEQRES 8 B 392 LEU PRO ARG ASN ILE ALA VAL PRO TYR CYS GLN LEU SER SEQRES 9 B 392 LYS LYS LEU GLU LEU PRO PRO ILE LEU VAL TYR ALA ASP SEQRES 10 B 392 CYS VAL LEU ALA ASN TRP LYS LYS LYS ASP PRO ASN LYS SEQRES 11 B 392 PRO LEU THR TYR GLU ASN MET ASP VAL LEU PHE SER PHE SEQRES 12 B 392 ARG ASP GLY ASP CYS SER LYS GLY PHE PHE LEU VAL SER SEQRES 13 B 392 LEU LEU VAL GLU ILE ALA ALA ALA SER ALA ILE LYS VAL SEQRES 14 B 392 ILE PRO THR VAL PHE LYS ALA MET GLN MET GLN GLU ARG SEQRES 15 B 392 ASP THR LEU LEU LYS ALA LEU LEU GLU ILE ALA SER CYS SEQRES 16 B 392 LEU GLU LYS ALA LEU GLN VAL PHE HIS GLN ILE HIS ASP SEQRES 17 B 392 HIS VAL ASN PRO LYS ALA PHE PHE SER VAL LEU ARG ILE SEQRES 18 B 392 TYR LEU SER GLY TRP LYS GLY ASN PRO GLN LEU SER ASP SEQRES 19 B 392 GLY LEU VAL TYR GLU GLY PHE TRP GLU ASP PRO LYS GLU SEQRES 20 B 392 PHE ALA GLY GLY SER ALA GLY GLN SER SER VAL PHE GLN SEQRES 21 B 392 CYS PHE ASP VAL LEU LEU GLY ILE GLN GLN THR ALA GLY SEQRES 22 B 392 GLY GLY HIS ALA ALA GLN PHE LEU GLN ASP MET ARG ARG SEQRES 23 B 392 TYR MET PRO PRO ALA HIS ARG ASN PHE LEU CYS SER LEU SEQRES 24 B 392 GLU SER ASN PRO SER VAL ARG GLU PHE VAL LEU SER LYS SEQRES 25 B 392 GLY ASP ALA GLY LEU ARG GLU ALA TYR ASP ALA CYS VAL SEQRES 26 B 392 LYS ALA LEU VAL SER LEU ARG SER TYR HIS LEU GLN ILE SEQRES 27 B 392 VAL THR LYS TYR ILE LEU ILE PRO ALA SER GLN GLN PRO SEQRES 28 B 392 LYS GLU ASN LYS THR SER GLU ASP PRO SER LYS LEU GLU SEQRES 29 B 392 ALA LYS GLY THR GLY GLY THR ASP LEU MET ASN PHE LEU SEQRES 30 B 392 LYS THR VAL ARG SER THR THR GLU LYS SER LEU LEU LYS SEQRES 31 B 392 GLU GLY HET HEM A 501 43 HET HU6 A 502 19 HET HEM B 501 43 HET HU6 B 502 19 HET ACY B 503 4 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM HU6 (1~{R},2~{S})-2-[[(6-BROMANYL-1~{H}-INDAZOL-4-YL) HETNAM 2 HU6 AMINO]METHYL]CYCLOHEXAN-1-OL HETNAM ACY ACETIC ACID HETSYN HEM HEME FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 4 HU6 2(C14 H18 BR N3 O) FORMUL 7 ACY C2 H4 O2 FORMUL 8 HOH *22(H2 O) HELIX 1 AA1 PRO A 33 PHE A 35 5 3 HELIX 2 AA2 TYR A 36 HIS A 45 1 10 HELIX 3 AA3 HIS A 45 SER A 52 1 8 HELIX 4 AA4 GLN A 54 LEU A 62 1 9 HELIX 5 AA5 ASP A 72 GLY A 93 1 22 HELIX 6 AA6 PRO A 104 GLU A 119 1 16 HELIX 7 AA7 VAL A 125 VAL A 130 1 6 HELIX 8 AA8 THR A 144 GLU A 146 5 3 HELIX 9 AA9 CYS A 159 ALA A 175 1 17 HELIX 10 AB1 SER A 176 LYS A 179 5 4 HELIX 11 AB2 VAL A 180 MET A 190 1 11 HELIX 12 AB3 GLU A 192 HIS A 215 1 24 HELIX 13 AB4 GLN A 216 VAL A 221 1 6 HELIX 14 AB5 ASN A 222 VAL A 229 1 8 HELIX 15 AB6 VAL A 229 SER A 235 1 7 HELIX 16 AB7 ASN A 240 SER A 244 5 5 HELIX 17 AB8 SER A 263 GLN A 266 5 4 HELIX 18 AB9 SER A 267 GLY A 278 1 12 HELIX 19 AC1 GLY A 286 ARG A 296 1 11 HELIX 20 AC2 ARG A 297 MET A 299 5 3 HELIX 21 AC3 PRO A 300 ASN A 313 1 14 HELIX 22 AC4 SER A 315 SER A 322 1 8 HELIX 23 AC5 ASP A 325 ILE A 354 1 30 HELIX 24 AC6 ILE A 354 SER A 359 1 6 HELIX 25 AC7 MET A 385 LYS A 397 1 13 HELIX 26 AC8 PRO B 33 PHE B 35 5 3 HELIX 27 AC9 TYR B 36 HIS B 45 1 10 HELIX 28 AD1 HIS B 45 SER B 52 1 8 HELIX 29 AD2 GLN B 54 LYS B 61 1 8 HELIX 30 AD3 ASP B 72 GLY B 93 1 22 HELIX 31 AD4 PRO B 104 GLU B 119 1 16 HELIX 32 AD5 VAL B 125 VAL B 130 1 6 HELIX 33 AD6 THR B 144 GLU B 146 5 3 HELIX 34 AD7 CYS B 159 SER B 176 1 18 HELIX 35 AD8 ALA B 177 LYS B 179 5 3 HELIX 36 AD9 VAL B 180 MET B 190 1 11 HELIX 37 AE1 GLU B 192 HIS B 215 1 24 HELIX 38 AE2 GLN B 216 VAL B 221 1 6 HELIX 39 AE3 ASN B 222 SER B 228 1 7 HELIX 40 AE4 VAL B 229 SER B 235 1 7 HELIX 41 AE5 ASN B 240 SER B 244 5 5 HELIX 42 AE6 SER B 263 GLN B 266 5 4 HELIX 43 AE7 SER B 267 LEU B 277 1 11 HELIX 44 AE8 GLY B 286 MET B 295 1 10 HELIX 45 AE9 ARG B 296 MET B 299 5 4 HELIX 46 AF1 PRO B 300 SER B 312 1 13 HELIX 47 AF2 SER B 315 SER B 322 1 8 HELIX 48 AF3 ASP B 325 TYR B 353 1 29 HELIX 49 AF4 ILE B 354 SER B 359 1 6 HELIX 50 AF5 MET B 385 LYS B 397 1 13 SHEET 1 AA1 2 VAL A 102 LEU A 103 0 SHEET 2 AA1 2 VAL A 248 TYR A 249 1 O VAL A 248 N LEU A 103 SHEET 1 AA2 2 LYS A 135 LYS A 136 0 SHEET 2 AA2 2 MET A 148 ASP A 149 -1 O ASP A 149 N LYS A 135 SHEET 1 AA3 2 LYS B 135 LYS B 136 0 SHEET 2 AA3 2 MET B 148 ASP B 149 -1 O ASP B 149 N LYS B 135 SSBOND 1 CYS A 308 CYS B 308 1555 1555 1.91 LINK NE2 HIS A 346 FE HEM A 501 1555 1555 2.00 LINK FE HEM A 501 N18 HU6 A 502 1555 1555 2.02 LINK NE2 HIS B 346 FE HEM B 501 1555 1555 2.03 LINK FE HEM B 501 N18 HU6 B 502 1555 1555 1.99 CISPEP 1 ASP A 383 LEU A 384 0 -10.86 CISPEP 2 LEU B 384 MET B 385 0 -1.40 CRYST1 85.686 96.345 130.226 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011671 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010379 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007679 0.00000